The Synthesis and Activity Evaluation of a Bestatin Derivative (LYP) as an Aminopeptidase N Inhibitor

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|6|6|420-423

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.6, 2009-09, pp. : 420-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition

By  

Medicinal Chemistry, Vol. 7, Iss. 1, 2011-01 ,pp. : 32-36

Bentham Science Publishers

Access to resources Recommend Favorite

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

By Gao Jian-Jun  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 574-582

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis of N-Benzenesulfonylbenzotriazole Derivatives, and Evaluation of their Antimicrobial Activity

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 5, 2008-07 ,pp. : 313-318

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advance in Aminopeptidase N (APN/CD13) Inhibitor Research

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 5011-5021

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and pharmacological evaluation of new N-methyl-arylpyrrolidinols with analgesic activity

By Collina S.   Azzolina O.   Vercesi D.   Brusotti G.   Rossi D.   Barbieri A.   Lanza E.   Mennuni L.   Alcaro S.   Battaglia D.   Linati L.   Ghislandi V.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 939-946

Elsevier

Access to resources Recommend Favorite